Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.4430
-0.0143-3.13%
Volume:277.61K
Turnover:125.73K
Market Cap:8.64M
PE:-0.41
High:0.4700
Open:0.4700
Low:0.4390
Close:0.4573
Loading ...

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

PR Newswire
·
13 Nov 2024

Acurx Pharmaceuticals Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
11 Nov 2024

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"

ACCESSWIRE
·
01 Nov 2024

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)

ACCESSWIRE
·
28 Oct 2024

Acurx’s ibezapostat shows favorable effect in Phase 2b CDI trial

TIPRANKS
·
21 Oct 2024

Acurx Announces New Bile Acid and Microbiome Analyses From Ph2b Trial of Ibezapolstat in Cdi Patients Presented at Idweek Scientific Conference

THOMSON REUTERS
·
21 Oct 2024

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference

PR Newswire
·
21 Oct 2024

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

PR Newswire
·
17 Oct 2024

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024

PR Newswire
·
16 Oct 2024

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST

ACCESSWIRE
·
11 Oct 2024

BRIEF-Acurx Announces Additional Ibezapolstat Ph2b Results In Cdi As Well As Anthrax Susceptibility To Acx-375 Analogues

Reuters
·
26 Sep 2024

Acurx Pharmaceuticals : Confirmed Ibezapolstat's Favorable Pharmacokinetics Showing Low Systemic Exposure and High Colonic Concentrations

THOMSON REUTERS
·
26 Sep 2024

Acurx Pharmaceuticals Inc: New Analyses Extend Data on Beneficial Effects of Ibezapolstat on Gut Microbiome

THOMSON REUTERS
·
26 Sep 2024

Acurx Announces Additional Ibezapolstat Ph2b Results in Cdi as Well as Anthrax (B. Anthracis) Susceptibility to Acx-375 Analogues

THOMSON REUTERS
·
26 Sep 2024

Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues

PR Newswire
·
26 Sep 2024

BRIEF-Acurx Announces Results Of Its Pioneering Research With Ibezapolstat

Reuters
·
24 Sep 2024